Family Medicine · Phoenix, AZ
NPI
1104856475
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4350 N 19th Ave, Suite 6
Phoenix, AZ, 85015
Phone (602) 264-9191
Groups this clinician bills Medicare through
Medicare paid, 2024
$126K
17,230 services
Medicare patients, 2024
248
Average age 69
Drug cost, 2024
$6.4M
9,036 prescriptions
Company payments, 2025
$254K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas L Cunningham was code J1071 (injection, testosterone cypionate, 1 mg), 14,200 times for 14 patients. In total Douglas L Cunningham billed 17,230 services in 60 codes, and Medicare paid $126K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 14,200 | 14 | $0.02 | $222 |
| 99214 Office E&M - Established | Office | 935 | 222 | $83.06 | $78K |
| 99213 Office E&M - Established | Office | 263 | 152 | $53.09 | $14K |
| 81002 Clinical Chemistry | Office | 235 | 76 | $3.40 | $798 |
| 96372 Injection Administration | Office | 232 | 66 | $9.91 | $2,299 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 128 | 20 | $0.09 | $11.16 |
| 82947 Clinical Chemistry | Office | 125 | 44 | $3.85 | $481 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 118 | 33 | $0.98 | $116 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 90 | 19 | $0.32 | $28.89 |
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 84 | 27 | $0.03 | $2.1 |
| 99497 Care Management/Coordination | Office | 73 | 72 | $65.43 | $4,776 |
| G0008 Administration of influenza virus vaccine | Office | 70 | 69 | $31.38 | $2,197 |
| 93000 Electrocardiogram | Office | 68 | 64 | $9.39 | $639 |
| 90653 Vaccine Product | Office | 52 | 52 | $81.82 | $4,255 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 49 | 49 | $17.30 | $848 |
By year: 2022 $165K for 23,852 services; 2023 $159K for 14,969 services; 2024 $126K for 17,230 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 235 | 76 | $3.40 | $798 |
| 82947 Clinical Chemistry | 125 | 44 | $3.85 | $481 |
| 82272 Immunoassay | 28 | 28 | $4.02 | $112 |
| 87804 Immunoassay | 26 | 12 | $16.22 | $422 |
| 87426 Immunoassay | 22 | 20 | $34.62 | $762 |
Medicare prescription drug claims, 2024
In 2024, the drug Douglas L Cunningham prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 530 prescriptions and refills. In total Douglas L Cunningham wrote 9,036 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 530 | 538 | 68 | $2.1M |
| Atorvastatin Calcium Generic | 420 | 660 | 97 | $2,323 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 339 | 374 | 74 | $7,469 |
| Lisinopril Generic | 276 | 465 | 76 | $1,150 |
| Gabapentin Generic | 242 | 305 | 46 | $2,727 |
| Rosuvastatin Calcium Generic | 216 | 345 | 44 | $1,687 |
| Metformin Hcl Generic | 205 | 350 | 54 | $903 |
| Levothyroxine Sodium Generic | 205 | 416 | 58 | $1,276 |
| Fluticasone Propionate Generic | 182 | 313 | 60 | $2,170 |
| Omeprazole Generic | 179 | 271 | 41 | $1,879 |
| Dovato Dolutegravir Sodium/Lamivudine | 174 | 180 | 22 | $520K |
| Pantoprazole Sodium Generic | 163 | 249 | 38 | $1,111 |
| Amlodipine Besylate Generic | 161 | 271 | 41 | $707 |
| Acyclovir Generic | 156 | 224 | 28 | $2,024 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 154 | 202 | 23 | $982 |
Brand drugs: 2,418 claims; generic drugs: 6,537 claims; opioid claims: 49.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas L Cunningham $254K ($254K in general payments such as food, travel and fees) from 11 companies. The largest payer was ViiV Healthcare Company with $164K.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 224 | $164K |
| Gilead Sciences, Inc. GILD | 103 | $66K |
| EMD Serono, Inc. MRK.DE | 21 | $9,037 |
| Theratechnologies Inc. THTX | 18 | $8,981 |
| Merck Sharp & Dohme LLC MRK | 16 | $5,082 |
| Napo Pharmaceuticals Inc | 4 | $69.83 |
| Novo Nordisk Inc NVO | 3 | $59.73 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $59.14 |
| Abbott Laboratories ABT | 1 | $23.02 |
| Abbvie Inc. ABBV | 1 | $21.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.